Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
486 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00636805 | Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab | terminated | Phase 2 | 63 | Duke UniversityOTHER | 1 | Apr 1, 2014 | clinicaltrials |
| NCT00611325 | Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma | completed | Phase 2 | 56 | Duke UniversityOTHER | 1 | Mar 12, 2014 | clinicaltrials |
| NCT01017250 |
| Radiosurgery and Avastin for Recurrent Malignant Gliomas |
| completed |
| N/A |
| 15 |
| Duke UniversityOTHER |
| 1 |
| Feb 28, 2014 |
| clinicaltrials |
| NCT00887640 | Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer | terminated | Phase 2 | 11 | Duke UniversityOTHER | 1 | Feb 26, 2014 | clinicaltrials |
| NCT00003434 | Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer | terminated | Phase 1 | 8 | Duke UniversityOTHER | 1 | Feb 10, 2014 | clinicaltrials |
| NCT00938769 | Enhanced Self-Efficacy Training | completed | N/A | 358 | Duke UniversityOTHER | 1 | Feb 7, 2014 | clinicaltrials |
| NCT00939146 | Outlook: An Intervention to Improve Quality of Life in Serious Illness | completed | N/A | 154 | Duke UniversityOTHER | 1 | Feb 7, 2014 | clinicaltrials |
| NCT00276627 | Computer Program in Improving Communication Between Doctors and Patients With Stage IV Cancer | completed | N/A | 800 | Duke UniversityOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT01898481 | Triadic Expectations: Decision Making in the Context of Cancer Treatment | completed | — | 38 | Duke UniversityOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT00590603 | Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma(AAV) | terminated | Phase 1 | 25 | Duke UniversityOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT00978939 | Impact of Aggressive Versus Standard Drainage Regimen Using a Long Term Indwelling Pleural Catheter(ASAP) | completed | Phase 4 | 150 | Duke UniversityOTHER | 1 | Dec 30, 2013 | clinicaltrials |
| NCT00636090 | Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001 | completed | — | 35 | Duke UniversityOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00586417 | A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments | terminated | N/A | 61 | Duke UniversityOTHER | 1 | Dec 3, 2013 | clinicaltrials |
| NCT00811655 | Stereotactic Radiosurgery in Treating Patients With Brain Metastases | terminated | Phase 2 | 6 | Duke UniversityOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT00814983 | Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft | terminated | Phase 1 / Phase 2 | 15 | Duke UniversityOTHER | 0 | Nov 25, 2013 | clinicaltrials |
| NCT00003432 | Immunotherapy in Treating Patients With Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 4 | Duke UniversityOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00620932 | Exercise Training Among Men With Prostate Cancer | withdrawn | N/A | 0 | Duke UniversityOTHER | 1 | Oct 28, 2013 | clinicaltrials |
| NCT00636571 | Feasibility of Exercise With Post-Op Lung Cancer Patients | completed | N/A | 21 | Duke UniversityOTHER | 1 | Oct 28, 2013 | clinicaltrials |
| NCT00873665 | Erectile Dysfunction Study | completed | N/A | 64 | Duke UniversityOTHER | 1 | Oct 28, 2013 | clinicaltrials |
| NCT00612430 | Ph II Bevacizumab + Etoposide for Pts w Recurrent MG | completed | Phase 2 | 59 | Duke UniversityOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00672243 | Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme | completed | Phase 2 | 32 | Duke UniversityOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00476827 | A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain | terminated | Phase 2 | 16 | Duke UniversityOTHER | 1 | Jul 17, 2013 | clinicaltrials |
| NCT00546104 | Phase II Dasatinib Study in Advanced Breast Cancer | completed | Phase 2 | 31 | Duke UniversityOTHER | 1 | Jul 17, 2013 | clinicaltrials |
| NCT01041326 | Preoperative Radiation Therapy for High Risk Prostate Cancer | completed | Phase 1 | 15 | Duke UniversityOTHER | 1 | Jul 17, 2013 | clinicaltrials |
| NCT00613028 | Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan | completed | Phase 2 | 23 | Duke UniversityOTHER | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00788216 | Development & Validation of Utilities for Health States Relevant to Cervical Cancer Patients | completed | — | 60 | Duke UniversityOTHER | 1 | Jul 15, 2013 | clinicaltrials |
| NCT01038492 | p16 Methylation for Smoking Cessation | completed | N/A | 35 | Duke UniversityOTHER | 1 | Jun 28, 2013 | clinicaltrials |
| NCT00597493 | Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM | completed | Phase 2 | 32 | Duke UniversityOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00002751 | Monoclonal Antibody Therapy in Treating Patients With Brain Metastases | completed | Phase 1 / Phase 2 | 6 | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00002988 | Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma | completed | Phase 1 | 36 | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00003464 | Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme | completed | Phase 2 | 50 | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00003465 | Temozolomide in Treating Patients With Anaplastic Oligodendroglioma | completed | Phase 2 | 60 | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00003467 | Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma | completed | Phase 2 | 68 | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00005952 | Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors | completed | Phase 1 / Phase 2 | 30 | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00005954 | Temozolomide in Treating Patients With Brain Metastases | completed | Phase 2 | — | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00005955 | Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors | completed | Phase 2 | — | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00006474 | Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma | completed | Phase 1 | — | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00016991 | ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse | completed | Phase 2 | — | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00612638 | Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas | completed | Phase 1 | 96 | Duke UniversityOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00674791 | Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease | completed | Phase 1 | 13 | Duke UniversityOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00873132 | BTC Neuropsychological Database | withdrawn | — | 0 | Duke UniversityOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT01115036 | A Panobinostat Presurgery(CLBH589C) | withdrawn | Phase 2 | 0 | Duke UniversityOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00523939 | DepoCyt for Active Lymphomatous or Leukemic Meningitis | terminated | Phase 2 | 4 | Duke UniversityOTHER | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00629395 | Computerized Cognitive Training for Childhood Cancer Survivors | terminated | N/A | 9 | Duke UniversityOTHER | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00873184 | Study of Massage Therapy Within a Brain Tumor Setting | completed | N/A | 10 | Duke UniversityOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00501891 | Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma | completed | Phase 2 | 32 | Duke UniversityOTHER | 1 | May 27, 2013 | clinicaltrials |
| NCT00612339 | Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas | completed | Phase 2 | 41 | Duke UniversityOTHER | 1 | May 27, 2013 | clinicaltrials |
| NCT00671970 | Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG) | completed | Phase 2 | 57 | Duke UniversityOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT01687231 | Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets | completed | N/A | 47 | Duke UniversityOTHER | 1 | May 10, 2013 | clinicaltrials |
| NCT00815152 | Coping With High Grade Glioma | terminated | N/A | 14 | Duke UniversityOTHER | 1 | May 6, 2013 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials